| N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer E Dardenne, H Beltran, M Benelli, K Gayvert, A Berger, L Puca, J Cyrta, ... Cancer cell 30 (4), 563-577, 2016 | 562 | 2016 |
| N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer A Berger, NJ Brady, R Bareja, B Robinson, V Conteduca, MA Augello, ... The Journal of clinical investigation 129 (9), 3924-3940, 2019 | 170 | 2019 |
| Spectral-domain optical coherence tomography of the rodent eye: highlighting layers of the outer retina using signal averaging and comparison with histology A Berger, S Cavallero, E Dominguez, P Barbe, M Simonutti, JA Sahel, ... PloS one 9 (5), e96494, 2014 | 128 | 2014 |
| Pharmacological disruption of the Notch transcription factor complex R Lehal, J Zaric, M Vigolo, C Urech, V Frismantas, N Zangger, L Cao, ... Proceedings of the National Academy of Sciences 117 (28), 16292-16301, 2020 | 87 | 2020 |
| Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa A Berger, S Lorain, C Joséphine, M Desrosiers, C Peccate, T Voit, ... Molecular Therapy 23 (5), 918-930, 2015 | 86 | 2015 |
| mRNA trans‐splicing in gene therapy for genetic diseases A Berger, S Maire, MC Gaillard, JA Sahel, P Hantraye, AP Bemelmans Wiley Interdisciplinary Reviews: RNA 7 (4), 487-498, 2016 | 78 | 2016 |
| Deciphering the molecular basis of invasiveness in Sdhb-deficient cells C Loriot, M Domingues, A Berger, M Menara, M Ruel, A Morin, ... Oncotarget 6 (32), 32955, 2015 | 71 | 2015 |
| Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network P Dhingra, A Martinez-Fundichely, A Berger, FW Huang, AN Forbes, ... Genome biology 18, 1-23, 2017 | 37 | 2017 |
| Lentiviral vectors for ocular gene therapy Y Arsenijevic, A Berger, F Udry, C Kostic Pharmaceutics 14 (8), 1605, 2022 | 33 | 2022 |
| Assessment of human nter and cter BRCA1 mutations using growth and localization assays in yeast GA Millot, A Berger, V Lejour, JB Boulé, C Bobo, C Cullin, J Lopes, ... Human mutation 32 (12), 1470-1480, 2011 | 28 | 2011 |
| Characterization of the ERG-regulated kinome in prostate cancer identifies TNIK as a potential therapeutic target RS Lee, L Zhang, A Berger, MG Lawrence, J Song, B Niranjan, ... Neoplasia 21 (4), 389-400, 2019 | 27 | 2019 |
| Retinoblastoma: From genes to patient care Y Bouchoucha, A Matet, A Berger, AM Carcaboso, A Gerrish, A Moll, ... European Journal of Medical Genetics 66 (1), 104674, 2023 | 22 | 2023 |
| AR-V7 exhibits non-canonical mechanisms of nuclear import and chromatin engagement in castrate-resistant prostate cancer S Kim, CMC Au, MAB Jamalruddin, NE Abou-Ghali, E Mukhtar, L Portella, ... Elife 11, e73396, 2022 | 22 | 2022 |
| Precision molecular pathology of prostate cancer BD Robinson, JM Mosquera, JY Ro, M Divatia Springer International Publishing, 2018 | 12 | 2018 |
| Tumor dormancy: EMT beyond invasion and metastasis P Aouad, HM Quinn, A Berger, C Brisken genesis 62 (1), e23552, 2024 | 10 | 2024 |
| Enhancer of zeste homolog 2 (EZH2) contributes to rod photoreceptor death process in several forms of retinal degeneration and its activity can serve as a biomarker for therapy … M Mbefo, A Berger, K Schouwey, X Gérard, C Kostic, A Beryozkin, ... International Journal of Molecular Sciences 22 (17), 9331, 2021 | 6 | 2021 |
| An in vitro Model of Human Retinal Detachment Reveals Successive Death Pathway Activations J Potic, M Mbefo, A Berger, M Nicolas, D Wanner, C Kostic, A Matet, ... Frontiers in Neuroscience 14, 571293, 2020 | 5 | 2020 |
| The role of androgen receptor in prostate cancer A Berger, DS Rickman Precision Molecular Pathology of Prostate Cancer, 345-365, 2018 | 5 | 2018 |
| Translational screening platform to evaluate chemotherapy in combination with focal therapy for retinoblastoma IL Sinenko, F Kuttler, V Simeonov, A Moulin, P Aouad, C Stathopoulos, ... Cancer Science 114 (9), 3728-3739, 2023 | 2 | 2023 |
| ERG and AR-v7 involvement in taxane resistance of metastatic castration-resistant prostate cancers A Berger, S Kim, A Gjyrezi, G Galletti, A Sboner, MA Rubin, S Tagawa, ... Cancer Research 76 (14_Supplement), 2125-2125, 2016 | 1 | 2016 |
